TY - JOUR T1 - Drug treatment of pruritus in liver diseases JF - Clinical Medicine JO - Clin Med SP - 351 LP - 357 DO - 10.7861/clinmedicine.15-4-351 VL - 15 IS - 4 AU - Vinod S Hegade AU - Stuart FW Kendrick AU - David EJ Jones Y1 - 2015/08/01 UR - http://www.rcpjournals.org/content/15/4/351.abstract N2 - Pruritus (itch) is a common complication of cholestatic liver diseases (CLD). It can be a distressing and debilitating symptom, causing significant impairment in quality of life. Treatment of pruritus in liver diseases can be challenging and requires specific management with early initiation and a step-wise approach using specific drugs. Clinical trials are ongoing with novel agents that demonstrate potential efficacy. Patients with cholestatic pruritus are likely to present to a variety of clinicians who would benefit from medical awareness of available treatment options. In this review, we outline the pharmaceutical agents currently used to treat cholestatic pruritus and provide the evidence base for targeted symptom control of itch in liver diseases. We also highlight recent developments in the pathophysiology of cholestatic pruritus and the emerging novel therapies. ER -